TRIPS
113 articles related to "TRIPS"
-
Access to medicines in resource-limited settings: the end of a golden decade?
Strong international mobilization and political will drove a golden decade for global health. Key initiatives over the last decade include setting of health-related Millennium Development Goals; the...
In Medical Journals / Research Articles – Last updated 29 March 2012
www.msfaccess.org/content/access-medicines-resource-limited-settings-end-golden-decade -
India Issues First Compulsory Licence
Groundbreaking Move Sets Precedent for Overcoming Drug Price Barriers India 2008 © Jean-Marc Giboux/Getty Images 12 March 2012, New Delhi/Geneva – In a landmark case, the Indian...
Press Release – Last updated 12 April 2012
www.msfaccess.org/about-us/media-room/press-releases/india-issues-first-compulsory-licence -
Submission to the US Trade Representative Regarding the 2012 Special 301 Review Process
Excerpt: "Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2012 Special 301 Process. MSF also request...
Statements, Speeches, Letters – Last updated 10 February 2012
www.msfaccess.org/content/submission-us-trade-representative-regarding-2012-special-301-review-process -
MSF Intervention at the 17th Session of WIPO Standing Committee on Law of Patents
Thanks Mr. Chairman. I am speaking on behalf of Médecins Sans Frontières International. MSF is a medical humanitarian organisation that works in over 80 countries around the world. We...
Statements, Speeches, Letters – Last updated 07 December 2011
www.msfaccess.org/content/msf-intervention-17th-session-wipo-standing-committee-law-patents -
Revising TRIPS for Public Health: Full Video
Multimedia – Last updated 25 November 2011
www.msfaccess.org/content/revising-trips-public-health-full-video -
Trade and Public Health: a Decade of Double Standards
At the heart of almost every dispute about access to medicines lies this question: how do countries balance the need to protect public health against patent rights that lead to high medicine prices...
Op-eds & Articles – Last updated 22 November 2011
www.msfaccess.org/content/trade-and-public-health-decade-double-standards -
What Novartis Says... and Why it's wrong
TAKE ACTION: As the Indian Supreme Court readies to hear the Novartis case, MSF tells Novartis to STOP its attack on India, the pharmacy of the developing world. Join MSF & tell Novartis patients...
Briefing – Last updated 03 October 2011
www.msfaccess.org/content/what-novartis-says-and-why-its-wrong -
The Global Politics of Pharmaceutical Monopoly Power
Every day, Médecins Sans Frontières (MSF) is confronted with the lack of access to adequate or affordable medical tools in the field. We face two major challenges the high cost of existing...
Report – Last updated 16 January 2009
www.msfaccess.org/content/global-politics-pharmaceutical-monopoly-power -
Provisions in U.S. Domestic Health Care Legislation Could Limit Access to Vaccines and New Class of Drugs
The international medical humanitarian organization Médecins Sans Frontières (MSF) is concerned that a little-discussed provision in the proposed U.S. domestic health care legislation...
Web article – Last updated 12 January 2010
www.msfaccess.org/content/provisions-us-domestic-health-care-legislation-could-limit-access-vaccines-and-new-class -
New Report highlights India's role as "lifeline" for patients in developing countries
AIDS treatment has seen progress in recent years, with about four million people starting treatment between 2003 and 2008, due largely to India's ability to produce low-cost quality medicines. Indian-produced...
Web article – Last updated 20 September 2010
www.msfaccess.org/content/new-report-highlights-indias-role-lifeline-patients-developing-countries-0

